Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis C
- 1 March 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 28 (3) , 382-389
- https://doi.org/10.1016/s0168-8278(98)80310-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infectionJournal of Hepatology, 1997
- Recombinant human granulocyte colony-stimulating factor reduces hepatitis c virus replication in mononuclear cells from chronic hepatitis c patientsCytokine, 1996
- CYTOKINES: COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSESAnnual Review of Biochemistry, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Hematopoietic Growth FactorsNew England Journal of Medicine, 1989
- Mechanisms of Action of InterferonsSeminars in Liver Disease, 1989
- INTERFERONS AND THEIR ACTIONSAnnual Review of Biochemistry, 1987
- Human granulocyte-macrophage colony-stimulating factor is a neutrophil activatorNature, 1985
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981